<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Anmol Seth, Julia Stiller" />

<meta name="date" content="2023-12-19" />

<title>Extended Abstract: Analysis of Panitumumab Randomized Trial</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Extended Abstract: Analysis of Panitumumab
Randomized Trial</h1>
<h4 class="author">Anmol Seth, Julia Stiller</h4>
<h4 class="date">2023-12-19</h4>



<div id="background-and-motivation" class="section level1">
<h1>Background and Motivation</h1>
<div id="introduction" class="section level4">
<h4>Introduction</h4>
<p>The Panitumumab Randomized trial In combination with chemotherapy for
Metastatic colorectal cancer to determine Efficacy (PRIME) is a pivotal
study in the field of oncology. Conducted by Douillard et al.Â in 2014,
the study focused on evaluating the efficacy of panitumumab-FOLFOX4
compared to FOLFOX4 alone as first-line treatment for wild-type (WT)
KRAS metastatic colorectal cancer (mCRC).</p>
</div>
<div id="significance-of-the-prime-study" class="section level4">
<h4>Significance of the PRIME Study</h4>
<p>The PRIME study demonstrated that panitumumab-FOLFOX4 significantly
improved progression-free survival (PFS) compared to FOLFOX4 in patients
with WT KRAS mCRC. This improvement in PFS, along with other key
findings, suggests the potential of panitumumab as an effective
treatment option for a specific subset of mCRC patients.</p>
</div>
<div id="context-within-scientific-research" class="section level4">
<h4>Context within Scientific Research</h4>
<p>Colorectal cancer remains a significant global health concern, and
advancements in treatment strategies are crucial for improving patient
outcomes. The PRIME study contributes valuable insights into the
effectiveness of targeted therapies, emphasizing the importance of
molecular profiling, such as KRAS testing, in treatment
decision-making.</p>
</div>
<div id="implications-for-healthcare" class="section level4">
<h4>Implications for Healthcare</h4>
<p>The positive benefit-risk profile observed in the PRIME study raises
important considerations for healthcare practitioners. Understanding the
impact of panitumumab-FOLFOX4 on both progression-free survival and
overall survival in WT KRAS mCRC patients is vital for informed clinical
decision-making.</p>
</div>
<div id="research-gap-addressed" class="section level4">
<h4>Research Gap Addressed</h4>
<p>The study addresses a notable research gap by providing evidence for
the efficacy and safety of panitumumab-FOLFOX4 in previously untreated
WT KRAS mCRC patients. This information is critical for identifying
patients who would benefit the most from this treatment regimen.</p>
</div>
<div id="motivation-for-analysis" class="section level4">
<h4>Motivation for Analysis</h4>
<p>Given the significance of the PRIME study, our analysis aims to
further explore and validate the findings. We seek to leverage
statistical methods to gain a deeper understanding of the impact of
panitumumab-FOLFOX4 on key clinical outcomes, thereby contributing to
the broader knowledge base in oncology.</p>
</div>
</div>
<div id="research-question-and-statistical-experiment" class="section level1">
<h1>Research Question and Statistical Experiment</h1>
<div id="research-questions" class="section level2">
<h2>Research Questions</h2>
<p><strong>âDoes the presence of KRAS mutations significantly impact the
survival outcomes of metastatic colorectal cancer patients receiving
different treatment regimens, specifically Panitumumab in combination
with FOLFOX and FOLFOX alone?â</strong></p>
<div id="statistical-experiment" class="section level4">
<h4>Statistical Experiment</h4>
<ol style="list-style-type: decimal">
<li><p><strong>Null Hypothesis (H0):</strong> There is no significant
difference in survival outcomes between patients with the âMutantâ and
âWild-typeâ KRAS genotypes, regardless of the treatment arm.</p></li>
<li><p><strong>Alternative Hypothesis (H1):</strong> There is a
significant difference in survival outcomes between patients with the
âMutantâ and âWild-typeâ KRAS genotypes, and this difference is
influenced by the treatment arm (Panitumumab + FOLFOX vs.Â FOLFOX
alone).</p></li>
<li><p><strong>Variables:</strong></p>
<ul>
<li><strong>Dependent Variable:</strong> Time to death (Survival
Time)</li>
<li><strong>Independent Variable 1:</strong> KRAS Genotype (Categorical:
Mutant, Wild-type)</li>
<li><strong>Independent Variable 2:</strong> Treatment Arm (Categorical:
Panitumumab + FOLFOX, FOLFOX alone)</li>
</ul></li>
<li><p><strong>Statistical Tests:</strong></p>
<ul>
<li><strong>Kaplan-Meier Survival Analysis:</strong> To visualize and
compare the survival curves for different genotypes and treatment
arms.</li>
<li><strong>Cox Proportional Hazards Model:</strong> To quantify the
hazard ratios and assess the impact of genotype and treatment on
survival.</li>
</ul></li>
<li><p><strong>Significance Level (Î±):</strong> Set a predetermined
significance level (e.g., Î± = 0.05) to determine statistical
significance.</p></li>
</ol>
<p><strong>Does the combination of Genotype and Treatment Arm have a
significant impact on patient survival outcomes?</strong> Null
Hypothesis (H0): The combination of Genotype and Treatment Arm does not
significantly impact patient survival outcomes. Alternative Hypothesis
(H1): The combination of Genotype and Treatment Arm significantly
impacts patient survival outcomes.</p>
<p><strong>Are there differences in the occurrence of adverse events
between patients receiving Panitumumab in combination with FOLFOX and
those receiving FOLFOX alone?</strong> Null Hypothesis (H0): There is no
significant difference in the occurrence of adverse events between
treatment arms. Alternative Hypothesis (H1): There is a significant
difference in the occurrence of adverse events between treatment
arms.</p>
<p><strong>Are there significant differences in the survival
distribution over time between different genotypes?</strong> Null
Hypothesis (H0): There is no significant difference in the survival
distribution over time among different genotypes. Alternative Hypothesis
(H1): There are significant differences in the survival distribution
over time among different genotypes.</p>
<p><strong>Does the treatment arm influence the survival distribution
over time within each genotype?</strong> Null Hypothesis (H0): The
treatment arm does not significantly influence the survival distribution
over time within each genotype. Alternative Hypothesis (H1): The
treatment arm significantly influences the survival distribution over
time within each genotype.</p>
</div>
</div>
</div>
<div id="data-cleaning-and-exploration" class="section level1">
<h1>Data Cleaning and Exploration</h1>
<div id="prepare-environment-and-dataset" class="section level2">
<h2>Prepare Environment and Dataset</h2>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(haven)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a><span class="fu">library</span>(purrr)</span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a><span class="fu">library</span>(ggplot2)</span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a><span class="fu">library</span>(knitr)</span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a><span class="fu">library</span>(survival)</span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a><span class="fu">library</span>(survminer)</span>
<span id="cb1-8"><a href="#cb1-8" tabindex="-1"></a></span>
<span id="cb1-9"><a href="#cb1-9" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;get_genotype.R&quot;</span>)</span>
<span id="cb1-10"><a href="#cb1-10" tabindex="-1"></a></span>
<span id="cb1-11"><a href="#cb1-11" tabindex="-1"></a>trial_path <span class="ot">=</span> <span class="fu">file.path</span>(<span class="st">&quot;..&quot;</span>, <span class="st">&quot;Final Project&quot;</span>, <span class="st">&quot;NCT00364013&quot;</span>)</span>
<span id="cb1-12"><a href="#cb1-12" tabindex="-1"></a>trial_files <span class="ot">=</span> <span class="fu">list.files</span>(trial_path, <span class="at">pattern =</span> <span class="st">&quot;*_pds2019.sas7bdat&quot;</span>)</span>
<span id="cb1-13"><a href="#cb1-13" tabindex="-1"></a></span>
<span id="cb1-14"><a href="#cb1-14" tabindex="-1"></a>dl <span class="ot">=</span> <span class="fu">map</span>(<span class="fu">file.path</span>(trial_path, trial_files), <span class="sc">~</span> <span class="fu">read_sas</span>(.x))</span>
<span id="cb1-15"><a href="#cb1-15" tabindex="-1"></a><span class="fu">names</span>(dl) <span class="ot">=</span> <span class="fu">gsub</span>(<span class="st">&quot;*_pds2019.sas7bdat&quot;</span>, <span class="st">&quot;&quot;</span>, trial_files)</span>
<span id="cb1-16"><a href="#cb1-16" tabindex="-1"></a></span>
<span id="cb1-17"><a href="#cb1-17" tabindex="-1"></a><span class="co"># Read in required data</span></span>
<span id="cb1-18"><a href="#cb1-18" tabindex="-1"></a>adae <span class="ot">=</span> dl<span class="sc">$</span>adae <span class="co">#contains adverse events</span></span>
<span id="cb1-19"><a href="#cb1-19" tabindex="-1"></a>adsl <span class="ot">=</span> dl<span class="sc">$</span>adsl <span class="co">#contains subject-level data</span></span>
<span id="cb1-20"><a href="#cb1-20" tabindex="-1"></a>biomark <span class="ot">=</span> dl<span class="sc">$</span>biomark <span class="co">#contains biomarkers</span></span>
<span id="cb1-21"><a href="#cb1-21" tabindex="-1"></a></span>
<span id="cb1-22"><a href="#cb1-22" tabindex="-1"></a><span class="co"># Select columns relevant to analysis</span></span>
<span id="cb1-23"><a href="#cb1-23" tabindex="-1"></a>filtered_biomark <span class="ot">&lt;-</span> biomark <span class="sc">%&gt;%</span></span>
<span id="cb1-24"><a href="#cb1-24" tabindex="-1"></a>  <span class="fu">select</span>(<span class="fu">c</span>(<span class="dv">1</span><span class="sc">:</span><span class="dv">7</span>, <span class="dv">16</span><span class="sc">:</span><span class="dv">17</span>))</span>
<span id="cb1-25"><a href="#cb1-25" tabindex="-1"></a></span>
<span id="cb1-26"><a href="#cb1-26" tabindex="-1"></a><span class="co"># Utilize our get_genotype() function on each subject ID</span></span>
<span id="cb1-27"><a href="#cb1-27" tabindex="-1"></a>filtered_biomark<span class="sc">$</span>Genotype <span class="ot">&lt;-</span> <span class="fu">sapply</span>(filtered_biomark<span class="sc">$</span>SUBJID, get_genotype)</span>
<span id="cb1-28"><a href="#cb1-28" tabindex="-1"></a></span>
<span id="cb1-29"><a href="#cb1-29" tabindex="-1"></a><span class="co"># Create master table by joining biomarker data with treatment and death metrics</span></span>
<span id="cb1-30"><a href="#cb1-30" tabindex="-1"></a>d <span class="ot">=</span> <span class="fu">left_join</span>(filtered_biomark, </span>
<span id="cb1-31"><a href="#cb1-31" tabindex="-1"></a>              adsl[, <span class="fu">c</span>(<span class="st">&quot;SUBJID&quot;</span>, <span class="st">&quot;ATRT&quot;</span>, <span class="st">&quot;DTH&quot;</span>, <span class="st">&quot;DTHDY&quot;</span>)], </span>
<span id="cb1-32"><a href="#cb1-32" tabindex="-1"></a>              <span class="at">by =</span> <span class="st">&quot;SUBJID&quot;</span>)</span>
<span id="cb1-33"><a href="#cb1-33" tabindex="-1"></a></span>
<span id="cb1-34"><a href="#cb1-34" tabindex="-1"></a><span class="co"># Temp table to get unique adverse events</span></span>
<span id="cb1-35"><a href="#cb1-35" tabindex="-1"></a>adverse_events_temp <span class="ot">&lt;-</span> adae <span class="sc">|&gt;</span></span>
<span id="cb1-36"><a href="#cb1-36" tabindex="-1"></a>  <span class="fu">group_by</span>(SUBJID, AEPT) <span class="sc">|&gt;</span></span>
<span id="cb1-37"><a href="#cb1-37" tabindex="-1"></a>  <span class="fu">summarize</span>(<span class="at">n =</span> <span class="fu">n</span>())</span>
<span id="cb1-38"><a href="#cb1-38" tabindex="-1"></a></span>
<span id="cb1-39"><a href="#cb1-39" tabindex="-1"></a><span class="co"># Count the number of adverse events per subject</span></span>
<span id="cb1-40"><a href="#cb1-40" tabindex="-1"></a>adverse_events_per_subject <span class="ot">&lt;-</span> adverse_events_temp <span class="sc">|&gt;</span></span>
<span id="cb1-41"><a href="#cb1-41" tabindex="-1"></a>  <span class="fu">group_by</span>(SUBJID) <span class="sc">|&gt;</span></span>
<span id="cb1-42"><a href="#cb1-42" tabindex="-1"></a>  <span class="fu">summarize</span>(<span class="at">adverse_events =</span> <span class="fu">n</span>())</span>
<span id="cb1-43"><a href="#cb1-43" tabindex="-1"></a></span>
<span id="cb1-44"><a href="#cb1-44" tabindex="-1"></a><span class="co"># Join adverse events</span></span>
<span id="cb1-45"><a href="#cb1-45" tabindex="-1"></a>d <span class="ot">&lt;-</span> d <span class="sc">|&gt;</span></span>
<span id="cb1-46"><a href="#cb1-46" tabindex="-1"></a>  <span class="fu">left_join</span>(adverse_events_per_subject, <span class="at">by =</span> <span class="st">&quot;SUBJID&quot;</span>)</span>
<span id="cb1-47"><a href="#cb1-47" tabindex="-1"></a></span>
<span id="cb1-48"><a href="#cb1-48" tabindex="-1"></a><span class="co"># Replace NA adverse events with 0</span></span>
<span id="cb1-49"><a href="#cb1-49" tabindex="-1"></a>d<span class="sc">$</span>adverse_events <span class="ot">&lt;-</span> <span class="fu">if_else</span>(<span class="fu">is.na</span>(d<span class="sc">$</span>adverse_events), <span class="dv">0</span>, d<span class="sc">$</span>adverse_events)</span></code></pre></div>
</div>
<div id="visualize-dataset" class="section level2">
<h2>Visualize dataset</h2>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a>d <span class="sc">|&gt;</span> <span class="fu">group_by</span>(Genotype) <span class="sc">|&gt;</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>  <span class="fu">summarize</span>(<span class="at">Count =</span> <span class="fu">n</span>()) <span class="sc">|&gt;</span></span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>  <span class="fu">ggplot</span>(<span class="fu">aes</span>(<span class="at">x =</span> Genotype, <span class="at">y =</span> Count, <span class="at">fill =</span> Genotype)) <span class="sc">+</span></span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>    <span class="fu">geom_bar</span>(<span class="at">stat =</span> <span class="st">&quot;identity&quot;</span>) <span class="sc">+</span></span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>    <span class="fu">labs</span>(<span class="at">title =</span> <span class="st">&quot;KRAS Mutation Status&quot;</span>, <span class="at">x =</span> <span class="st">&quot;Genotype&quot;</span>, <span class="at">y =</span> <span class="st">&quot;Count&quot;</span>) <span class="sc">+</span></span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>    <span class="fu">theme_minimal</span>() <span class="sc">+</span></span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>    <span class="fu">theme</span>(<span class="at">axis.text.x =</span> <span class="fu">element_text</span>(<span class="at">angle =</span> <span class="dv">45</span>, <span class="at">hjust =</span> <span class="dv">1</span>)) <span class="sc">+</span>  </span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a>    <span class="fu">geom_text</span>(<span class="fu">aes</span>(<span class="at">label =</span> Count), <span class="at">vjust =</span> <span class="sc">-</span><span class="fl">0.5</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a></span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a>d <span class="sc">|&gt;</span></span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a>    <span class="fu">filter</span>(Genotype <span class="sc">!=</span> <span class="st">&quot;Unknown&quot;</span>) <span class="sc">|&gt;</span> <span class="co">#ignore unknown genotypes</span></span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a>    <span class="fu">group_by</span>(ATRT) <span class="sc">|&gt;</span></span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a>    <span class="fu">summarize</span>(<span class="at">Count =</span> <span class="fu">n</span>()) <span class="sc">|&gt;</span></span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a>    <span class="fu">ggplot</span>(<span class="fu">aes</span>(<span class="at">x =</span> ATRT, <span class="at">y =</span> Count, <span class="at">fill =</span> ATRT)) <span class="sc">+</span></span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a>    <span class="fu">geom_bar</span>(<span class="at">stat =</span> <span class="st">&quot;identity&quot;</span>) <span class="sc">+</span></span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a>    <span class="fu">labs</span>(<span class="at">title =</span> <span class="st">&quot;Treatments&quot;</span>, <span class="at">x =</span> <span class="st">&quot;Treatment&quot;</span>, <span class="at">y =</span> <span class="st">&quot;Count&quot;</span>) <span class="sc">+</span></span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a>    <span class="fu">theme_minimal</span>() <span class="sc">+</span></span>
<span id="cb3-10"><a href="#cb3-10" tabindex="-1"></a>    <span class="fu">theme</span>(<span class="at">axis.text.x =</span> <span class="fu">element_text</span>(<span class="at">angle =</span> <span class="dv">45</span>, <span class="at">hjust =</span> <span class="dv">1</span>)) <span class="sc">+</span>  </span>
<span id="cb3-11"><a href="#cb3-11" tabindex="-1"></a>    <span class="fu">geom_text</span>(<span class="fu">aes</span>(<span class="at">label =</span> Count), <span class="at">vjust =</span> <span class="sc">-</span><span class="fl">0.5</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAAEgCAMAAAAjXV6yAAABgFBMVEUAAAAAADoAAGYAOjoAOmYAOpAAZrYAv8Q6AAA6ADo6AGY6OgA6OmY6OpA6ZmY6ZpA6ZrY6kJA6kLY6kNtNTU1NTWRNTW5NTY5NbqtNjqtNjshmAABmADpmAGZmOgBmOmZmZmZmkJBmkNtmtttmtv9uTU1uTW5uTY5ubo5ubqtujo5ujshuq6tuq8huq+SOTU2OTW6OTY6Obk2OjsiOyMiOyOSOyP+QOgCQOjqQZgCQZjqQZmaQkDqQkGaQkLaQtpCQttuQ27aQ2/+rbk2rbm6rbo6rbqurjm6rjsirq+SryKur5OSr5P+2ZgC2Zjq2kDq2tpC2ttu225C229u22/+2/7a2///Ijk3Iq47Iq6vIyI7IyOTI5P/I/8jI/+TI///bkDrbtmbbtpDb25Db27bb29vb/7bb/9vb///kq27kq47kyI7k5Kvk5OTk5P/k/8jk///r6+v4dm3/tmb/yI7/yKv/25D/27b/29v/5Kv/5Mj//7b//8j//9v//+T////o6rY6AAAACXBIWXMAAA7DAAAOwwHHb6hkAAAM3ElEQVR4nO2di3vbVhXAlXTx3I49IKaEhJXCknXAlvB0Ol4dScczhjFKDAMWdzxmAx3NbDxMbOtf3zn3IV09jyRfx7J0fl8/25Ku+8m/3PfRlRyXScVZ9QmUHRZEwIIIWBABCyJgQQQsiIAFERQTdLXnKDbPU5KNv5x2NG+y1bBUQb3Uo3mTrYbiRWx2vNUnkrAg+d7oOZuP3E/uOM5nHuGex885zsZX4QDksO1xc/txE7aGTedFTK+Twdffec5P5s6+D196xc6PsokNQTeazlZ/3MQSt3ECGUIWvn0t6AU4svEADzegvtHJxFE/mdrct/bDbGFDEPz94RX//B80G/AJshOIaMiyA0ZecR9jHhk3t/pmMqfRB5lespf68kslw4YgrEKgJOGGrE7+/s4Pmv4vb2ClDmnxC34y+bWrPS/Zja/8zsYPso0NQfg+VK0aFB5ZinxB28qD29nq+8nk16ACU1Y7uPvFR7Z+lzXsC4IuwAs//u0/9nIKcj+4Q/UaVoItQeOmrl/lJ6MOMgX5ySKCgL+9Wb5a2pYgqH3fgjYcKhZQ08fGHPb2RIEzBfnJTEGQbOh8Dmqp32ArWC5sCdJlbNtrv1GQ7AcZgsxkviC/mSf7nteONUHuGOqQG9jTw67gM291oNxc3XEafw0K8pIZgjBZX3QUXyqdHx7NU7AgAhZEwIIIWBABCyJgQQQsiIAFEbAggmKCxjdPxFSiGjuJTde9tHhepWGxHHSZslURigm6TMfyOa4UzkEELIjAjqBnTRY/qTJRVNDHJiwoCgsiYEEELIiABSHz07brTo9aO0+9Nw0LQgattpA02NVvHiwImLz27bY7/daFO7l3od68YywICtjDX0G2mXztqTv95pl6U4cuLwOCLgOCajMWGxxiuRrtCDPqzTvIOQizzjwpB7EgF2to5JDroBQwB81PD2UrdsitWATuB3FPmoQFEbAgAhZEwIIIWBBB0bhYQFBNx2KpcA4iKCaoJxcGqfUIDf1p29hX8HyWxrUKmh3fVasO5OUOs2Ox9ketT1CXQJSMaxU03HxXrdUICHI7DX9f2bhWQZ2tD49lGWJBcVztbeuVPQFBQ4eLmGAoVkcZMrx1q66/r2xcpyAsSbNjoziJHKRWabIgfTcCUcbMIjZc1xw0arW+cGFxwkxWP2pBolkHdcx6qWykTNrfuzAihosHDlXhkm+hftDatmL+bP3ik/Z6uSouwAw186KDvZaCIM9w4NDnak/8jYd6EfLk4PYZBw6Nz2FBrpF1OHCo70kSHFF32xw49FE5SKEKFQcOExm0WlAHceDQQN2WJMsNNGopSHXlMlFLQcE6KJ1aCpodL1XQx7EscvLXQaAOGma/fU8tBem7Iy6pkl5/QdkpNBark6Ca5iAuYjFEc9DVl7JMy9RYkDvMcp8s64JkL35bDpqhuzG+dR63u4cn19n2/1eVbmnECVpJEdM/FA1gAE0LCu12O/vu+HnjL7gCQZ3V5CD5Q69ePpcbQUHebrDz4X1ZB2Dm2hf7oPLEkNvzb4pMJrdsEVNJZ7pV37IEyfINffqgIG835KW7soBhXalEQpEbytugYjrY6tm7SKQ0zfxY3i54KH9aZ9+sg4zd5i0tRcaCdJi9QJfIX7AF4mSGs0KKoMlBq2XzQvJsOUjFhsI5SO92Z/cf6Cqogz0SlYlm9z1Be1lLQSaCgnqqyUBwBnry6pm9BXV26iBQJRsxnHuQ6UI5yF7uQQKCevIOxtLQCHXYnJPOJEicQ1wrpnbjz5f7hI+bJ0YdJAWpLUt+CkY1ljAW85rroeoHiQ5QI7RbhhpFZwiz+zN39o1WTAmCLYu3hE0VhDP19uJi6YLKSnIRw3r50LW4oK4CggKVNLRi0IZZXNRbBUEm0o/FBXVVEySXZLavqx9UVgxBoo7O8LwVQQFB64kvSF8r2Mk00quhoE4j/CGNAoKejWXB8186niA/aris+SAWVG1B+npB3ZEnqJ8g7/EfvqlkCo3F1l2Q2xFDPPGcIpoa5iA1gM44EK6loDywIALrgrwAWAB/ajErneglPEVDboLyCMKzjovqWhBUMOQmKJcgnJVX4S4Z5Brf+v2es/munCuc3f8R/MWH4nGAkT3qe27nrvekRD07nT/kVlpB45snOtzV1PPM6hehjuOGWPgSu0d9TzzETGWNkKDsIbdyCmr6aw9luMv17Hj55QTDO0YEw9ijjWARE8Vs6OhKrVDIrXyCvKpGh7vyChLfc3994tVD4RyUI+SWUZCYY7U2YZZNkB/uyidIfQ/l6ItR89ZBXsgtq6ARrji0FzjMJsgId3l2MIPgk0cNHZE96ns4WRNu93KH3DIK6t7+JeQge5P2GYuYH+6SdvCBrLDvsy8HClTsHvgetmLhwUD+kFs2QbKI2QscpgsqK6Qge4HDigqyFzisqKDrqoPKCimIF9SlYLcftJ7wLboIWBABCyJgQQQsiIAFEfCdOAk4BxGwIAIWRMCCCFgQAQsiYEEELIggsyCeD0qHn1BHwDd5IwjHxfhp4SHCcTEJPwzbIxwXk7Agj3AdJGFBHuG4mIQF+YT6QRIWxLAgAhZEwIIIWBABCyJgQQQsiMCqoNGhzf+tHFgV1GVB6Ywig7X1Z0FBMEJr+VZwTqRqLCYIZ6rFbZhwYceumBOpGosJgiwzPWoP8EZV35C302lVrZQtKOjeX47abldLgQzVbcmnklWG4oKw+gEfbbyXoMg9h5VsxooL6rah3vneKZaqAU6lTQ52Y+Yc156iguYPX7vAmhlvRKnmqicH7VF00nHdKSzon1i40JAMCSGDnX9HpvXXnuJFTLiRn5QgqLJ/YeGUykUxQVhB7/xLGHqCW1JVBQtYQUHYP5yfCkMiHw3wMVsiMlQ98gr6L6oQQwq05I6EGrcLbfz0qHpNmJtb0PwUjchmCzrQyo93c+4KkruICSddea9p8Xl+Wsmco8lfB6GVuegfuu8d7VbdT5FKWuSbyatYuKZHX6y4n7yCxADMq3ncqtbMBvkEYcsFDTv+U0165Q3lEzTCSbH3oL2a/+ygJobyCZrce/+0DTX0Ljbs9TCU+RpFpQPy0PztC/wkDVVcT3ZBeipssPN0cCjnx9CQmpCuMJlzkMooWL70/Njk4PXK+8l1lav+6M2PefVQhckiKBTR8efHKji7ESGDoEBE54k5P3ax1FMrBzkWs2BE5/PiORIVnh+LQAoKRHTkIKPK82MRKEGBiI4ehFV4fiwCISgQ0fGnf6o7PxaBEBSI6NRh+idCRkEyolOD6Z8IKYKgRQ+3WHWpeAySBcnAYKjFqp+hREEJLVbtDCUJ8qdVQy1W3QwlCAoHdHBao1upC6OykiAo0qLHrqerA0lFLNKiY11URxIr6VBd0935T/Unx+KIEaSmnwOGpj9/6k5/enE951QqooK8iE7d2qt44orYhA35xNZBXkRn1A4tNqgfYUGBiM78tNXutus3gjcJCQpHdMSjNbwhax0JCopGdNSQtZYtvCAoKCaiI68o4xzkxkV05NVAFVzCkwNf0CgS0fGvBlrRyZUBT1BMRMe7GqjOaEFx82PG1UD1RQmKRHSg+mmbVwPVFiUoPP8D1Q9WPeJqoBWdWUnQRSw0/zP9jugN1b18uUYlbY5MoXxhBxoMreKUyoXfzBuGupB1xJijFhe4pGN0FLWh+al4tGE9p6AjmEMNZUiutmRDkpgZxYdnou88/+OfV3A+pSMq6P9/uH1W79FFgLgZxREb8gkJgvLlmnFnJiQIy5eLz6BlQ4pgK4bLmHFB4dvvf7SyMyoZhiA1/hq1Xudwj4/ZUZTjL7cOCwyyY4zFePwVhyeIx1/xKEE8/kpCC+LxVwJSEI+/EpGCePyViBHVYENxOH/i8VcqzsEbp1/n8VcyzvTojY94/JWMM/ju0SGPv5Jx5FX0PP5KwmnLoCE3YAk4MhC/+2TVJ1JWHO79pOO4bCgVh+2k43D+SYcfPELAgghYEAELImBBBCyIgAURsCACFkTAgghYEAELImBBBCyIgAURsCACFkTAgghYEAELImBBBLSg2bEjacQf/+QR8R+QCUpNthw0vnlS4FDGBOWGBRHkETS+9UNn8xyL3OY5bDWh2G3j6/b45oOm+rwvyyQkkDv3RYLl/oalkktQs4E/H156W/2rPXDR2zzHQ+PmVt/tOfiCAmUCuVMmWGPyCQInQ8w9YOd/fblfCtpXR2FLJ9DbdRKErz3ZpEGpGcLbhhSEB/SLTqC3aydoqy92Xe1tnHg5KCBIJairoOGG/L1D9DCMyUE6QV0FzY7BDEhAD+PmxglW1gFBOoHeFrX5+pJbkGjFMZN04O0n8OM7TiMgSCfwtjtJffC1gMdiBCyIgAURsCACFkTAgghYEAELImBBBCyI4FO0wrm8cEPfwQAAAABJRU5ErkJggg==" /><!-- --></p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a></span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>d <span class="sc">|&gt;</span></span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a>    <span class="fu">filter</span>(Genotype <span class="sc">!=</span> <span class="st">&quot;Unknown&quot;</span>) <span class="sc">|&gt;</span> <span class="co">#ignore unknown genotypes</span></span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a>    <span class="fu">ggplot</span>(<span class="fu">aes</span>(<span class="at">x =</span> DTHDY, <span class="at">color =</span> Genotype)) <span class="sc">+</span></span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a>      <span class="fu">theme_minimal</span>() <span class="sc">+</span></span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a>      <span class="fu">geom_density</span>() <span class="sc">+</span></span>
<span id="cb4-7"><a href="#cb4-7" tabindex="-1"></a>      <span class="fu">labs</span>(<span class="at">title =</span> <span class="st">&quot;Survival Distribution Over Time&quot;</span>, <span class="at">x =</span> <span class="st">&quot;Time to Death (Days)&quot;</span>, <span class="at">y =</span> <span class="st">&quot;Density&quot;</span>) <span class="sc">+</span></span>
<span id="cb4-8"><a href="#cb4-8" tabindex="-1"></a>      <span class="fu">theme</span>(<span class="at">legend.position =</span> <span class="st">&quot;top&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div id="data-cleaning-and-exploration-summary" class="section level3">
<h3>Data Cleaning and Exploration Summary</h3>
<ol style="list-style-type: decimal">
<li><strong>Loading and Organizing the Data:</strong>
<ul>
<li>Utilized the <code>haven</code> and <code>purrr</code> libraries to
read SAS datasets into a list.</li>
<li>Extracted relevant datasets, including severity code, actual
treatment, confirmed responses, and biomarkers.</li>
</ul></li>
<li><strong>Biomarker Data Cleaning:</strong>
<ul>
<li>Selected pertinent columns for analysis from the biomarker
dataset.</li>
<li>Developed a function to determine the genotype based on biomarker
information.</li>
<li>Added a âGenotypeâ column to the filtered biomarker data.</li>
<li>Provided a summary table of the distribution of genotypes.</li>
</ul></li>
<li><strong>Merging Datasets:</strong>
<ul>
<li>Merged relevant datasets based on the âSUBJIDâ key, incorporating
biomarker information with actual treatment and patient outcomes.</li>
</ul></li>
<li><strong>Exploratory Data Analysis (EDA):</strong>
<ul>
<li>Generated summary tables and visualizations to explore the
distribution of genotypes, actual treatment, and patient outcomes.</li>
<li>Conducted exploratory analysis on ATRT and DTH distributions within
each genotype.</li>
</ul></li>
<li><strong>Visualization: KRAS Mutation Status:</strong>
<ul>
<li>Created a bar chart to visualize the distribution of KRAS mutation
status, providing a clear overview of the dataset.</li>
</ul></li>
<li><strong>Kaplan-Meier Survival Analysis:</strong>
<ul>
<li>Filtered out unknown genotypes for survival analysis.</li>
<li>Set factors and levels for genotype and actual treatment.</li>
<li>Conducted Kaplan-Meier survival analysis to assess the impact of
genotype and treatment arm on patient outcomes.</li>
<li>Presented Kaplan-Meier survival curves for different scenarios,
highlighting potential differences in survival probabilities.</li>
</ul></li>
<li><strong>Cox Proportional Hazards Model:</strong>
<ul>
<li>Fitted a Cox Proportional Hazards model to quantify the association
between genotype and the hazard of death.</li>
<li>Provided a summary of the modelâs coefficients and significance
levels.</li>
</ul></li>
</ol>
</div>
</div>
</div>
<div id="analysis" class="section level1">
<h1>Analysis</h1>
<div id="visualize-average-survival-by-genotype" class="section level2">
<h2>Visualize average survival by genotype</h2>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;plot_survival_days_genotype.R&quot;</span>)</span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a></span>
<span id="cb5-3"><a href="#cb5-3" tabindex="-1"></a><span class="fu">plot_survival_days_genotype</span>(d)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="analyze-whether-number-of-survival-days-differed-by-genotype" class="section level2">
<h2>Analyze whether number of survival days differed by genotype</h2>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;test_survival_days_genotype.R&quot;</span>)</span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a></span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a><span class="fu">test_survival_days_genotype</span>(d)</span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a><span class="co">#&gt;  Two Sample t-test</span></span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a><span class="co">#&gt; data:  mutant_survival_days and wild_type_survival_days</span></span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a><span class="co">#&gt; t = -3.9039, df = 864, p-value = 0.000102</span></span>
<span id="cb6-9"><a href="#cb6-9" tabindex="-1"></a><span class="co">#&gt; alternative hypothesis: true difference in means is not equal to 0</span></span>
<span id="cb6-10"><a href="#cb6-10" tabindex="-1"></a><span class="co">#&gt; 95 percent confidence interval:</span></span>
<span id="cb6-11"><a href="#cb6-11" tabindex="-1"></a><span class="co">#&gt;  -146.73053  -48.55124</span></span>
<span id="cb6-12"><a href="#cb6-12" tabindex="-1"></a><span class="co">#&gt; sample estimates:</span></span>
<span id="cb6-13"><a href="#cb6-13" tabindex="-1"></a><span class="co">#&gt; mean of x mean of y </span></span>
<span id="cb6-14"><a href="#cb6-14" tabindex="-1"></a><span class="co">#&gt;  571.6495  669.2904</span></span></code></pre></div>
<p>The two-sample t-test was conducted using the
test_survival_days_genotype function, comparing survival days between
patients with mutant and wild-type genotypes. The results indicate a
statistically significant difference in mean survival days, with
patients having a mutant genotype expected to live between 48 to 146
days fewer than those with a wild-type genotype (p-value = 0.000102, 95%
CI: -146.73053 to -48.55124). The mean survival days for the mutant
genotype group (571.6495) are notably lower than for the wild-type group
(669.2904).</p>
</div>
<div id="visualize-average-survival-by-genotype-1" class="section level2">
<h2>Visualize average survival by genotype</h2>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;plot_survival_days_treatment.R&quot;</span>)</span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a></span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a><span class="fu">plot_survival_days_treatment</span>(d)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="analyze-whether-number-of-survival-days-differed-by-treatment" class="section level2">
<h2>Analyze whether number of survival days differed by treatment</h2>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;test_survival_days_treatment.R&quot;</span>)</span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a><span class="fu">test_survival_days_treatment</span>(d)</span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a><span class="co">#&gt;  Two Sample t-test</span></span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a><span class="co">#&gt; data:  folfox_survival_days and folxfox_panitumumab_survival_days</span></span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a><span class="co">#&gt; t = 0.16625, df = 933, p-value = 0.868</span></span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a><span class="co">#&gt; alternative hypothesis: true difference in means is not equal to 0</span></span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a><span class="co">#&gt; 95 percent confidence interval:</span></span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a><span class="co">#&gt;  -43.27879  51.28986</span></span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a><span class="co">#&gt; sample estimates:</span></span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a><span class="co">#&gt; mean of x mean of y </span></span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a><span class="co">#&gt;  618.5910  614.5855</span></span></code></pre></div>
<p>The results of the two-sample t-test indicate no statistically
significant difference in mean survival days between patients receiving
FOLFOX alone and those receiving Panitumumab + FOLFOX (p-value = 0.868,
95% CI: -43.27879 to 51.28986). The mean survival days for patients in
the FOLFOX alone group (618.5910) are comparable to those in the
Panitumumab + FOLFOX group (614.5855).</p>
</div>
<div id="does-the-combination-of-genotype-and-treatment-arm-have-a-significant-impact-on-patient-survival-outcomes" class="section level2">
<h2>Does the combination of Genotype and Treatment Arm have a
significant impact on patient survival outcomes?</h2>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a><span class="co"># Filtering out unknown genotypes since these are not informative for this analysis</span></span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a>dcombo <span class="ot">&lt;-</span> <span class="fu">subset</span>(d, Genotype <span class="sc">!=</span> <span class="st">&quot;Unknown&quot;</span>)</span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a></span>
<span id="cb9-4"><a href="#cb9-4" tabindex="-1"></a>dcombo<span class="sc">$</span>Genotype <span class="ot">=</span> <span class="fu">factor</span>(dcombo<span class="sc">$</span>Genotype, <span class="at">ordered =</span> <span class="cn">FALSE</span>)</span>
<span id="cb9-5"><a href="#cb9-5" tabindex="-1"></a>dcombo<span class="sc">$</span>Genotype <span class="ot">=</span> <span class="fu">relevel</span>(dcombo<span class="sc">$</span>Genotype, <span class="at">ref =</span> <span class="st">&quot;Wild-type&quot;</span>)</span>
<span id="cb9-6"><a href="#cb9-6" tabindex="-1"></a></span>
<span id="cb9-7"><a href="#cb9-7" tabindex="-1"></a>dcombo<span class="sc">$</span>ATRT <span class="ot">=</span> <span class="fu">factor</span>(dcombo<span class="sc">$</span>ATRT, <span class="at">ordered =</span> <span class="cn">FALSE</span>)</span>
<span id="cb9-8"><a href="#cb9-8" tabindex="-1"></a>dcombo<span class="sc">$</span>ATRT <span class="ot">=</span> <span class="fu">relevel</span>(dcombo<span class="sc">$</span>ATRT, <span class="at">ref =</span> <span class="st">&quot;FOLFOX alone&quot;</span>)</span>
<span id="cb9-9"><a href="#cb9-9" tabindex="-1"></a></span>
<span id="cb9-10"><a href="#cb9-10" tabindex="-1"></a>surv_plot <span class="ot">&lt;-</span> <span class="fu">ggsurvplot</span>(</span>
<span id="cb9-11"><a href="#cb9-11" tabindex="-1"></a>  <span class="fu">survfit</span>(<span class="fu">Surv</span>(DTHDY, DTH) <span class="sc">~</span> Genotype <span class="sc">+</span> ATRT, <span class="at">data =</span> dcombo),</span>
<span id="cb9-12"><a href="#cb9-12" tabindex="-1"></a>  <span class="at">data =</span> dcombo,</span>
<span id="cb9-13"><a href="#cb9-13" tabindex="-1"></a>  <span class="at">conf.int =</span> <span class="cn">TRUE</span>,</span>
<span id="cb9-14"><a href="#cb9-14" tabindex="-1"></a>  <span class="at">legend.title =</span> <span class="st">&quot;Genotype &amp; ATRT&quot;</span>,</span>
<span id="cb9-15"><a href="#cb9-15" tabindex="-1"></a>  <span class="at">title =</span> <span class="st">&quot;Kaplan-Meier Survival Curve by Genotype &amp; Treatment Arm&quot;</span>,</span>
<span id="cb9-16"><a href="#cb9-16" tabindex="-1"></a>  <span class="at">xlab =</span> <span class="st">&quot;Time in Days&quot;</span>,</span>
<span id="cb9-17"><a href="#cb9-17" tabindex="-1"></a>  <span class="at">ylab =</span> <span class="st">&quot;Survival Probability&quot;</span>,</span>
<span id="cb9-18"><a href="#cb9-18" tabindex="-1"></a>  <span class="at">pval =</span> <span class="cn">TRUE</span></span>
<span id="cb9-19"><a href="#cb9-19" tabindex="-1"></a>)</span>
<span id="cb9-20"><a href="#cb9-20" tabindex="-1"></a></span>
<span id="cb9-21"><a href="#cb9-21" tabindex="-1"></a>surv_plot<span class="sc">$</span>plot <span class="sc">+</span> <span class="fu">geom_hline</span>(<span class="at">yintercept =</span> <span class="fl">0.5</span>, <span class="at">col =</span> <span class="st">&#39;red&#39;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>Here we can see the following:</p>
<ul>
<li><p>There are some statistically significant interactions with p &lt;
0.0001 although it is not specified what those interactions
are.</p></li>
<li><p>Subjects with a âWild-typeâ genotype generally show higher
survival rates over time.</p></li>
<li><p>Subjects with a âMutantâ genotype generally show lower survival
rates over time.</p></li>
<li><p>If a subject has the âWild-typeâ genotype, they may have an
improved survival rate if they receive âPanitumumab+FOLFOXâ instead of
âFOLFOX aloneâ</p></li>
<li><p>If a subject has the âMutantâ genotype, they may have an improved
survival rate if they receive âFOLFOX aloneâ instead of
âPanitumumab+FOLFOXâ</p></li>
</ul>
</div>
<div id="does-the-presence-of-kras-mutations-significantly-impact-the-survival-outcomes-of-metastatic-colorectal-cancer-patients-receiving-different-treatment-regimens-specifically-panitumumab-in-combination-with-folfox-and-folfox-alone" class="section level2">
<h2>Does the presence of KRAS mutations significantly impact the
survival outcomes of metastatic colorectal cancer patients receiving
different treatment regimens, specifically Panitumumab in combination
with FOLFOX and FOLFOX alone?</h2>
<p>The Kaplan-Meier curve assesses whether there are significant
differences in survival times among different genotypic groups .</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a><span class="fu">ggsurvplot</span>(</span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a>  <span class="fu">survfit</span>(<span class="fu">Surv</span>(DTHDY, DTH) <span class="sc">~</span> Genotype, <span class="at">data =</span> dcombo),</span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a>  <span class="at">data =</span> dcombo,</span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a>  <span class="at">conf.int =</span> <span class="cn">TRUE</span>,</span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a>  <span class="at">legend.title =</span> <span class="st">&quot;Genotype&quot;</span>,</span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a>  <span class="at">title =</span> <span class="st">&quot;Kaplan-Meier Survival Curve by Genotype&quot;</span>,</span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a>  <span class="at">xlab =</span> <span class="st">&quot;Time in Days&quot;</span>,</span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a>  <span class="at">ylab =</span> <span class="st">&quot;Survival Probability&quot;</span>,</span>
<span id="cb10-9"><a href="#cb10-9" tabindex="-1"></a>  <span class="at">risk.table =</span> <span class="cn">TRUE</span></span>
<span id="cb10-10"><a href="#cb10-10" tabindex="-1"></a>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" tabindex="-1"></a><span class="fu">summary</span>(<span class="fu">coxph</span>(<span class="fu">Surv</span>(dcombo<span class="sc">$</span>DTHDY, dcombo<span class="sc">$</span>DTH) <span class="sc">~</span> dcombo<span class="sc">$</span>Genotype))</span>
<span id="cb11-2"><a href="#cb11-2" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb11-3"><a href="#cb11-3" tabindex="-1"></a><span class="co">#&gt; coxph(formula = Surv(dcombo$DTHDY, dcombo$DTH) ~ dcombo$Genotype)</span></span>
<span id="cb11-4"><a href="#cb11-4" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb11-5"><a href="#cb11-5" tabindex="-1"></a><span class="co">#&gt;   n= 866, number of events= 633 </span></span>
<span id="cb11-6"><a href="#cb11-6" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb11-7"><a href="#cb11-7" tabindex="-1"></a><span class="co">#&gt;                          coef exp(coef) se(coef)     z Pr(&gt;|z|)    </span></span>
<span id="cb11-8"><a href="#cb11-8" tabindex="-1"></a><span class="co">#&gt; dcombo$GenotypeMutant 0.39599   1.48585  0.07992 4.955 7.23e-07 ***</span></span>
<span id="cb11-9"><a href="#cb11-9" tabindex="-1"></a><span class="co">#&gt; ---</span></span>
<span id="cb11-10"><a href="#cb11-10" tabindex="-1"></a><span class="co">#&gt; Signif. codes:  0 &#39;***&#39; 0.001 &#39;**&#39; 0.01 &#39;*&#39; 0.05 &#39;.&#39; 0.1 &#39; &#39; 1</span></span>
<span id="cb11-11"><a href="#cb11-11" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb11-12"><a href="#cb11-12" tabindex="-1"></a><span class="co">#&gt;                       exp(coef) exp(-coef) lower .95 upper .95</span></span>
<span id="cb11-13"><a href="#cb11-13" tabindex="-1"></a><span class="co">#&gt; dcombo$GenotypeMutant     1.486      0.673      1.27     1.738</span></span>
<span id="cb11-14"><a href="#cb11-14" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb11-15"><a href="#cb11-15" tabindex="-1"></a><span class="co">#&gt; Concordance= 0.543  (se = 0.011 )</span></span>
<span id="cb11-16"><a href="#cb11-16" tabindex="-1"></a><span class="co">#&gt; Likelihood ratio test= 24.54  on 1 df,   p=7e-07</span></span>
<span id="cb11-17"><a href="#cb11-17" tabindex="-1"></a><span class="co">#&gt; Wald test            = 24.55  on 1 df,   p=7e-07</span></span>
<span id="cb11-18"><a href="#cb11-18" tabindex="-1"></a><span class="co">#&gt; Score (logrank) test = 24.87  on 1 df,   p=6e-07</span></span></code></pre></div>
<ol style="list-style-type: decimal">
<li><strong>Cox Proportional Hazards Model:</strong>
<ul>
<li>The coefficient for <code>dcombo$GenotypeMutant</code> is 0.39534,
which is positive. This positive coefficient suggests that having the
âMutantâ genotype is associated with a higher hazard (risk) of death
compared to the âWild-typeâ reference group.</li>
</ul></li>
<li><strong>Log-Rank Test:</strong>
<ul>
<li>The log-rank test for the âGenotypeâ variable has a very small
p-value (p=8e-07). This suggests that there is a significant difference
in survival between different genotypes.</li>
</ul></li>
</ol>
<p>Patients with the âMutantâ genotype have a lower chance of survival
compared to those with the âWild-typeâ genotype, as indicated by the
positive coefficient and the significant log-rank test.</p>
</div>
<div id="are-there-differences-in-the-occurrence-of-adverse-events-between-patients-receiving-panitumumab-in-combination-with-folfox-and-those-receiving-folfox-alone" class="section level2">
<h2>Are there differences in the occurrence of adverse events between
patients receiving Panitumumab in combination with FOLFOX and those
receiving FOLFOX alone?</h2>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb12-1"><a href="#cb12-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;plot_adverse_events_genotype.R&quot;</span>)</span>
<span id="cb12-2"><a href="#cb12-2" tabindex="-1"></a></span>
<span id="cb12-3"><a href="#cb12-3" tabindex="-1"></a><span class="fu">plot_adverse_events_genotype</span>(d)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;test_adverse_events_genotype.R&quot;</span>)</span>
<span id="cb13-2"><a href="#cb13-2" tabindex="-1"></a></span>
<span id="cb13-3"><a href="#cb13-3" tabindex="-1"></a><span class="fu">test_adverse_events_genotype</span>(d)</span>
<span id="cb13-4"><a href="#cb13-4" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb13-5"><a href="#cb13-5" tabindex="-1"></a><span class="co">#&gt;  Two Sample t-test</span></span>
<span id="cb13-6"><a href="#cb13-6" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb13-7"><a href="#cb13-7" tabindex="-1"></a><span class="co">#&gt; data:  mutant_adverse_events and wild_type_adverse_events</span></span>
<span id="cb13-8"><a href="#cb13-8" tabindex="-1"></a><span class="co">#&gt; t = -0.78763, df = 864, p-value = 0.4311</span></span>
<span id="cb13-9"><a href="#cb13-9" tabindex="-1"></a><span class="co">#&gt; alternative hypothesis: true difference in means is not equal to 0</span></span>
<span id="cb13-10"><a href="#cb13-10" tabindex="-1"></a><span class="co">#&gt; 95 percent confidence interval:</span></span>
<span id="cb13-11"><a href="#cb13-11" tabindex="-1"></a><span class="co">#&gt;  -0.3479129  0.1486450</span></span>
<span id="cb13-12"><a href="#cb13-12" tabindex="-1"></a><span class="co">#&gt; sample estimates:</span></span>
<span id="cb13-13"><a href="#cb13-13" tabindex="-1"></a><span class="co">#&gt; mean of x mean of y </span></span>
<span id="cb13-14"><a href="#cb13-14" tabindex="-1"></a><span class="co">#&gt;  1.507353  1.606987</span></span></code></pre></div>
<p>The two-sample t-test results suggest no statistically significant
difference in the mean number of adverse events between patients with a
mutant genotype and those with a wild-type genotype (p-value = 0.4311,
95% CI: -0.3479129 to 0.1486450). The mean number of adverse events for
the mutant genotype group (1.507353) is comparable to that of the
wild-type genotype group (1.606987).</p>
<div class="sourceCode" id="cb14"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb14-1"><a href="#cb14-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;plot_adverse_events_treatment.R&quot;</span>)</span>
<span id="cb14-2"><a href="#cb14-2" tabindex="-1"></a></span>
<span id="cb14-3"><a href="#cb14-3" tabindex="-1"></a><span class="fu">plot_adverse_events_treatment</span>(d)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" tabindex="-1"></a><span class="fu">source</span>(<span class="st">&quot;test_adverse_events_treatment.R&quot;</span>)</span>
<span id="cb15-2"><a href="#cb15-2" tabindex="-1"></a></span>
<span id="cb15-3"><a href="#cb15-3" tabindex="-1"></a><span class="fu">test_adverse_events_treatment</span>(d)</span>
<span id="cb15-4"><a href="#cb15-4" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb15-5"><a href="#cb15-5" tabindex="-1"></a><span class="co">#&gt;  Two Sample t-test</span></span>
<span id="cb15-6"><a href="#cb15-6" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb15-7"><a href="#cb15-7" tabindex="-1"></a><span class="co">#&gt; data:  folfox_adverse_events and folxfox_panitumumab_adverse_events</span></span>
<span id="cb15-8"><a href="#cb15-8" tabindex="-1"></a><span class="co">#&gt; t = -21.443, df = 933, p-value &lt; 2.2e-16</span></span>
<span id="cb15-9"><a href="#cb15-9" tabindex="-1"></a><span class="co">#&gt; alternative hypothesis: true difference in means is not equal to 0</span></span>
<span id="cb15-10"><a href="#cb15-10" tabindex="-1"></a><span class="co">#&gt; 95 percent confidence interval:</span></span>
<span id="cb15-11"><a href="#cb15-11" tabindex="-1"></a><span class="co">#&gt;  -2.314831 -1.926636</span></span>
<span id="cb15-12"><a href="#cb15-12" tabindex="-1"></a><span class="co">#&gt; sample estimates:</span></span>
<span id="cb15-13"><a href="#cb15-13" tabindex="-1"></a><span class="co">#&gt; mean of x mean of y </span></span>
<span id="cb15-14"><a href="#cb15-14" tabindex="-1"></a><span class="co">#&gt;  0.496788  2.617521</span></span></code></pre></div>
<p>The two-sample t-test results indicate a highly significant
difference in the mean number of adverse events between patients
receiving FOLFOX alone and those receiving Panitumumab + FOLFOX (p-value
&lt; 2.2e-16, 95% CI: -2.314831 to -1.926636). The mean number of
adverse events for the FOLFOX alone group (0.496788) is substantially
lower than that of the Panitumumab + FOLFOX group (2.617521).</p>
<p><strong>Wild-type and mutant genotypes do not have different numbers
of adverse events during the trial (p&gt;0.05). However, we did find
that patients taking Folfox alone had an average of 2 fewer adverse
events than patients taking both Folfox combined with Panitumumab
(p&lt;0.05).</strong></p>
</div>
</div>
<div id="interpretations-and-conclusions" class="section level1">
<h1>Interpretations and Conclusions</h1>
<p>In this comprehensive analysis of the Panitumumab clinical trial
data, we explored various aspects related to patient outcomes, genotype,
and treatment arms. Our initial focus was on understanding the impact of
genotype and treatment on patient survival. The Kaplan-Meier survival
curves revealed significant differences between genotypes, with patients
having a âMutantâ genotype exhibiting lower survival rates compared to
those with a âWild-typeâ genotype. Additionally, the Cox Proportional
Hazards Model and log-rank test supported these findings, indicating
that patients with the âMutantâ genotype face a higher risk of
death.</p>
<p>Further investigations delved into the association between treatment
arms and survival. The survival analysis suggested that patients with a
âWild-typeâ genotype might experience improved survival when treated
with âPanitumumab + FOLFOXâ compared to âFOLFOX alone.â Conversely,
patients with a âMutantâ genotype may fare better with âFOLFOX aloneâ
than âPanitumumab + FOLFOX.â This nuanced understanding can guide
personalized treatment decisions based on genotype.</p>
<p>Exploring adverse events, we conducted t-tests to compare their
occurrence based on genotype and treatment. The results indicated no
significant difference in adverse events between genotypes. However, a
striking difference emerged when comparing treatment arms, revealing a
substantial increase in adverse events for patients receiving
âPanitumumab + FOLFOXâ compared to âFOLFOX alone.â</p>
<p>The two-sample t-tests for survival days highlighted significant
differences between genotypes. Patients with a âMutantâ genotype
generally had fewer days to live than those with a âWild-typeâ genotype,
emphasizing the clinical relevance of genetic information in predicting
outcomes.</p>
<p>In summary, our analyses provide a multifaceted understanding of the
Panitumumab clinical trial data. The results underscore the importance
of considering both genotype and treatment arms in predicting patient
outcomes. The observed differences in survival and adverse events
support the notion that a personalized approach, tailored to individual
genotypes, could enhance treatment efficacy and minimize adverse
effects. Moving forward, these findings suggest the need for further
exploration of genotype-specific treatment strategies and potential
biomarkers to refine patient stratification and optimize therapeutic
interventions.</p>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
